Clinical trial
A Value Affirmation Intervention for Physical Symptoms and Medication Adherence in Breast Cancer Patients Taking Aromatase Inhibitors
NCT04651452 is registered in ClinicalTrials.gov with Carnegie Mellon University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Value Affirmation Intervention for Physical Symptoms and Medication Adherence in Breast Cancer Patients Taking Aromatase Inhibitors
- Lead sponsor
- Carnegie Mellon University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2021
- Completion date
- April 30, 2026
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer